LAUSR

Karyopharm Therapeutics, Kite Pharma, Lundbeck, Merck, Roche/Genentech, Inc., Seattle Genetics, Takeda, Teva, TG Therapeutics; Research Funding: Roche/Genentech, Inc. Sharman, J: Consultant Advisory Role: Pharmacyclics, Celgene, TG Therapeutics, Genentech, Inc., AbbVie, Acerta Pharma/AstraZeneca; Research Funding: Pharmacyclics, Genentech, Inc., Celgene, Acerta Pharma, Gilead Sciences, Seattle Genetics, TG Therapeutics, Merck, Takeda; Other Remuneration: US Oncology (leadership), Gilead Sciences (expert testimony). Trněný, M: Consultant Advisory Role: Takeda, Bristol-Myers Squibb, Incyte, AbbVie, Amgen, Roche, Gilead Sciences, Janssen, Celgene, MorphoSys; Honoraria: Janssen, Gilead Sciences, Takeda, Bristol-Myers Squibb, Amgen, AbbVie, Roche, MorphoSys, Incyte; Other Remuneration: Gilead Sciences, Takeda, Bristol-Myers Squibb, Roche, Janssen, AbbVie (travel, accommodation and expenses). Lee, C: Employment Leadership Position: Roche; Stock Ownership: Roche. Salles, G: Consultant Advisory Role: Roche/Genentech, Inc., Gilead Sciences, Janssen, Celgene, Novartis, Merck, Pfizer, Acerta Pharma, Kite Pharma, Servier, MorphoSys, Epizyme; Honoraria: Roche/Genentech, Inc., Amgen, Janssen, Celgene, Servier, Gilead Sciences, Novartis, AbbVie, Merck, Takeda, MorphoSys.